No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
NLSP NLS Pharmaceutics
- 0.1345
- +0.0021+1.59%
Trading Apr 26 09:36 ET
5.84MMarket Cap-269P/E (TTM)
0.1345High0.1230Low9.83KVolume0.1230Open0.1324Pre Close1.28KTurnover0.04%Turnover RatioLossP/E (Static)43.39MShares1.530052wk High-1.36P/B3.38MFloat Cap0.113052wk Low--Dividend TTM25.16MShs Float7.3500Historical High--Div YieldTTM8.69%Amplitude0.1130Historical Low0.1300Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
NLS Pharmaceutics Receives Nasdaq Staff Delisting Determination
NLS Pharmaceutics Ltd Strategizes for Growth
Board Member Resigns From NLS Pharmaceutics Ltd.
NLS Pharmaceutics Announces Closing of $1.75 Million Registered Direct Offering
ZÜRICH, SWITZERLAND / ACCESSWIRE / March 22, 2024 / NLS Pharmaceutics Ltd. , a Swiss clinical-stage biopharmaceutical company focused on the
NLS Pharmaceutics Ltd. Announces New Warrant Issue
NLS Pharmaceutics Ltd. Addresses Financial Claims
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg